Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses

BACKGROUND: Emerging therapies such as closed-loop (CL) glucose control, also known as artificial pancreas (AP) systems, have shown significant improvement in type 1 diabetes mellitus (T1DM) management. However, demanding patient intervention is still required, particularly at meal times. To reduce...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Diabetes Sci Technol
Prif Awduron: Sánchez-Peña, Ricardo, Colmegna, Patricio, Garelli, Fabricio, De Battista, Hernán, García-Violini, Demián, Moscoso-Vásquez, Marcela, Rosales, Nicolás, Fushimi, Emilia, Campos-Náñez, Enrique, Breton, Marc, Beruto, Valeria, Scibona, Paula, Rodriguez, Cintia, Giunta, Javier, Simonovich, Ventura, Belloso, Waldo H., Cherñavvsky, Daniel, Grosembacher, Luis
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2018
Pynciau:
Special Section: Control Limitations in Models of T1DM and the Robustness of Optimal Insulin Delivery
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134619/
https://ncbi.nlm.nih.gov/pubmed/29998754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296818786488
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg